The role of mast cells in functional GI disorders

MM Wouters, M Vicario, J Santos - Gut, 2016 - gut.bmj.com
Functional gastrointestinal disorders (FGIDs) are characterized by chronic complaints
arising from disorganized brain-gut interactions leading to dysmotility and hypersensitivity …

Neurotransmitter dysfunction in irritable bowel syndrome: emerging approaches for management

M Gros, B Gros, JE Mesonero, E Latorre - Journal of Clinical Medicine, 2021 - mdpi.com
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose aetiology is
still unknown. Most hypotheses point out the gut-brain axis as a key factor for IBS. The axis is …

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

K McIntosh, DE Reed, T Schneider, F Dang… - Gut, 2017 - gut.bmj.com
Objective To gain mechanistic insights, we compared effects of low fermentable
oligosaccharides, disaccharides and monosaccharides and polyols (FODMAP) and high …

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation

M Vivinus-Nébot, G Frin-Mathy, H Bzioueche… - Gut, 2014 - gut.bmj.com
Objective To determine the role of colonic barrier defects and low-grade inflammation in
irritable bowel syndrome (IBS)-like symptoms in quiescent inflammatory bowel disease …

Colonic immune cells in irritable bowel syndrome: a systematic review and meta‐analysis

M Bashashati, S Moossavi, C Cremon… - …, 2018 - Wiley Online Library
Abstract Background & Aims Increases in mucosal immune cells have frequently been
observed in irritable bowel syndrome (IBS) patients. However, this finding is not completely …

Crosstalk at the mucosal border: importance of the gut microenvironment in IBS

L Öhman, H Törnblom, M Simren - Nature reviews Gastroenterology & …, 2015 - nature.com
The aetiology and pathology of IBS, a functional bowel disorder thought to lack an organic
cause, is largely unknown. However, studies suggest that various features, such as altered …

[HTML][HTML] Mast cells and irritable bowel syndrome: from the bench to the bedside

L Zhang, J Song, X Hou - Journal of neurogastroenterology and …, 2016 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is traditionally defined as a functional disorder since it lacks
demonstrable pathological abnormalities. However, in recent years, low grade inflammatory …

Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia

C Cirillo, T Bessissow, AS Desmet… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: An intact and well-functioning enteric nervous system is necessary to
efficiently organize gut function. Functional gastrointestinal disorders are pathological …

Mast cell regulation and irritable bowel syndrome: effects of food components with potential nutraceutical use

JA Uranga, V Martínez, R Abalo - Molecules, 2020 - mdpi.com
Mast cells are key actors in inflammatory reactions. Upon activation, they release histamine,
heparin and nerve growth factor, among many other mediators that modulate immune …

Randomised controlled trial of mesalazine in IBS

G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli… - Gut, 2016 - gut.bmj.com
Objective Low-grade intestinal inflammation plays a role in the pathophysiology of IBS. In
this trial, we aimed at evaluating the efficacy and safety of mesalazine in patients with IBS …